for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bioanalytical Systems, Inc.

BASI.OQ

Latest Trade

3.97USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1.18

 - 

4.40

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Bioanalytical Systems Posts Q3 Loss Per Share Of $0.04

Aug 14 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BASI CONTINUES REVENUE GROWTH IN THIRD QUARTER OF FISCAL 2019.Q3 LOSS PER SHARE $0.04.Q3 REVENUE ROSE 79.8 PERCENT TO $10.86 MILLION.

Bioanalytical Systems Inc Q2 Loss Per Share $0.06

May 15 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BASI CONTINUES REVENUE GROWTH IN SECOND QUARTER OF FISCAL 2019.Q2 LOSS PER SHARE $0.06.Q2 REVENUE ROSE 60.4 PERCENT TO $9.344 MILLION.

Basi Acquires The Smithers Avanza Toxicology Services Business Unit To Support Growing Toxicology Business And Broaden Scientific Talent

May 1 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BASI ACQUIRES THE SMITHERS AVANZA TOXICOLOGY SERVICES BUSINESS UNIT TO SUPPORT GROWING TOXICOLOGY BUSINESS AND BROADEN SCIENTIFIC TALENT.BIOANALYTICAL SYSTEMS INC - ACQUIRED BUSINESS WILL OPERATE AS A WHOLLY OWNED SUBSIDIARY OF BASI UNDER NAME BASI GAITHERSBURG.BIOANALYTICAL SYSTEMS INC - DEAL FOR APPROXIMATELY $1.2 MILLION IN CASH, 200,000 COMMON SHARES OF CO.BIOANALYTICAL SYSTEMS INC - DEAL ALSO INCLUDES AN UNSECURED SUBORDINATED PROMISSORY NOTE IN INITIAL PRINCIPAL AMOUNT OF $810,000.

Bioanalytical Systems Q4 Loss Per Share $0.02

Bioanalytical Systems Inc <BASI.O>::BASI CONTINUES REVENUE GAINS TO CLOSE FISCAL 2018.Q4 LOSS PER SHARE $0.02.Q4 REVENUE ROSE 53 PERCENT TO $8.986 MILLION.

Bioanalytical Systems - On Sept 28, Co, First Internet Bank Entered Into Amendment To Credit Agreement Dated June 23, 2017

Oct 4 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BIOANALYTICAL SYSTEMS - ON SEPT 28, CO, FIRST INTERNET BANK ENTERED INTO AMENDMENT TO CREDIT AGREEMENT DATED JUNE 23, 2017 - SEC FILING.BIOANALYTICAL SYSTEMS - AMENDMENT PROVIDES CO A CONSTRUCTION DRAW LOAN NOT TO EXCEED $4.4 MILLION AND AN EQUIPMENT DRAW LOAN NOT TO EXCEED $1.4 MILLION.BIOANALYTICAL SYSTEMS - EACH LOAN MATURES MARCH 28, 2025.

BASi Q3 Loss Per Share $0.01

Aug 14 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BASI REPORTS THIRD QUARTER RESULTS WITH REVENUE GAINS.Q3 LOSS PER SHARE $0.01.Q3 REVENUE ROSE 4 PERCENT TO $6.039 MILLION.

Basi Reports Q2 Earnings Per Share $0.01

May 15 (Reuters) - Bioanalytical Systems Inc <BASI.O>::BASI REPORTS SECOND QUARTER RESULTS.Q2 EARNINGS PER SHARE $0.01.Q2 REVENUE FELL 6 PERCENT TO $5.944 MILLION.

Bioanalytical Systems Q1 Earnings Per Share $0.00

Feb 14 (Reuters) - Bioanalytical Systems Inc <BASI.O>::Q1 EARNINGS PER SHARE $0.00.‍FOR THREE MONTHS ENDED DECEMBER 31, 2017, REVENUE AMOUNTED TO $5.4 MILLION, 13% DECREASE FROM $6.2 MILLION IN Q1 OF FISCAL 2017​.

Bioanalytical Systems Q1 Earnings Per Share $0.00

Feb 14 (Reuters) - Bioanalytical Systems Inc <BASI.O>::Q1 EARNINGS PER SHARE $0.00.‍FOR THREE MONTHS ENDED DECEMBER 31, 2017, REVENUE AMOUNTED TO $5.4 MILLION, 13% DECREASE FROM $6.2 MILLION IN Q1 OF FISCAL 2017​.

Bioanalytical Systems reports Q3 earnings per share of $0.03

Aug 14 (Reuters) - Bioanalytical Systems Inc <BASI.O>::Q3 earnings per share $0.03.Qtrly ‍revenue amounted to $5.8 million, up 15 percent.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up